IPOX Schuster LLC

News

IPOX Breaking News: IPOX 100 U.S. Index Holding Kite Pharma acquired at big premium / “FPX” ETF in focus !

IPOX Schuster LLC, the innovative Financial Products Design firm specializing in asset allocation-focused investment solutions for investors in IPOs and Spin-offs world-wide, is pleased to note the acquisition of Kite Pharma (KITE US) by U.S. drugmaker Gilead (GILD).

Kite Pharma is a portfolio holding in a number of IPOX Indexes, including the IPOX 100 U.S. Index (IPXO) which serves as the underlying for the USD million 853 First Trust US Equity Opportunities ETF (FPX).

Best Regards

The IPOX Team

Filed under News